(Q37138263)

English

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

scientific article published on February 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Hepatic artery embolization

1 reference

based on heuristic

inferred from title

Ronald P DeMatteo

19

object named as

Ronald DeMatteo

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Karen T Brown

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Richard K Do

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Mithat Gonen

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Anne M Covey

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

George I Getrajdman

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Constantinos T Sofocleous

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

William R Jarnagin

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Michael I D'Angelica

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Peter J Allen

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Joseph P Erinjeri

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Lynn A Brody

11

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Gerald P O'Neill

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Kristian N Johnson

13

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Alessandra R Garcia

14

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Christopher Beattie

15

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Binsheng Zhao

16

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Stephen B Solomon

17

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Lawrence H Schwartz

18

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ghassan K Abou-Alfa

20

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

1 February 2016

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

34

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

17

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

2046-2053

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

14 September 2017

Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

3 September 2018

Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

3 September 2018

A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

3 September 2018

Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4966514

3 September 2018

Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/26834067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26834067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26834067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants

1 reference

https://pubmed.ncbi.nlm.nih.gov/26834067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uterine artery embolization: a treatment option for symptomatic fibroids in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/26834067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-eluting Beads for Liver Embolization: Concentration of Doxorubicin in Tissue and in Beads in a Pig Model

1 reference

https://pubmed.ncbi.nlm.nih.gov/26834067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26834067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2015.64.0821

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37138263&oldid=1548089210"